Skip to content
PaperFren

Concept

Insulin resistance

Insulin resistance is reduced tissue response to insulin—often measured as lower insulin-stimulated glucose uptake or related metabolic fluxes—seen before overt type 2 diabetes and linked to cellular brakes (for example TXNIP), early mitochondrial energy defects, and population exposures such as night-shift work.

Students collapse “diabetes,” “insulin resistance,” and “metabolic syndrome” into one story. Mechanism papers, offspring physiology, and occupational epidemiology answer different questions that should stay separated.

Studies

4

Findings

4

4 supporting · 0 challenging · 4 qualifying citations

Open tensions

2

Currently

What we know

  1. TXNIP rises with impaired glucose handling and tracks lower muscle glucose uptake.
  2. Insulin barely raises muscle ATP synthesis in insulin-resistant offspring of parents with diabetes.
  3. Longer rotating night-shift work associates with higher type 2 diabetes risk in nurses.
  4. Gut microbiota composition associates with metabolites and metabolic-syndrome traits.

Largest unresolved question

Muscle TXNIP/ATP-flux studies explain peripheral disposal defects in small physiology samples; night-shift cohorts estimate diabetes incidence at population scale. They cohere as levels of analysis, not as interchangeable effect sizes.

Common misconceptions

  • Insulin resistance is just another name for type 2 diabetes.

    Insulin resistance can appear in offspring and prediabetes before diagnosis; diabetes incidence studies track later disease, not the same endpoint as clamp glucose uptake.

  • If gut microbes associate with metabolic traits, microbiota composition alone proves the cause of insulin resistance.

    Observational microbiota–metabolite links are associations; muscle physiology papers still measure host insulin action directly.

Related